Ironwood Investment Counsel LLC Acquires Shares of 1,676 UnitedHealth Group Inc (UNH)

Ironwood Investment Counsel LLC acquired a new position in shares of UnitedHealth Group Inc (NYSE:UNH) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,676 shares of the healthcare conglomerate’s stock, valued at approximately $328,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Regal Wealth Group Inc. boosted its stake in shares of UnitedHealth Group by 0.4% during the second quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock valued at $138,000 after purchasing an additional 3 shares during the period. Jackson Grant Investment Advisers Inc. boosted its stake in shares of UnitedHealth Group by 0.4% during the second quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock valued at $204,000 after purchasing an additional 4 shares during the period. RB Capital Management LLC boosted its stake in shares of UnitedHealth Group by 0.4% during the second quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock valued at $321,000 after purchasing an additional 7 shares during the period. Highland Private Wealth Management boosted its stake in shares of UnitedHealth Group by 0.4% during the second quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock valued at $593,000 after purchasing an additional 13 shares during the period. Finally, RNC Capital Management LLC boosted its stake in shares of UnitedHealth Group by 0.7% during the second quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock valued at $360,000 after purchasing an additional 13 shares during the period. 86.01% of the stock is owned by institutional investors.

In other news, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the transaction, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now owns 61,137 shares in the company, valued at approximately $13,652,503.47. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 34,630 shares of company stock worth $7,669,416. Corporate insiders own 0.89% of the company’s stock.

UnitedHealth Group Inc (NYSE:UNH) opened at $220.42 on Thursday. The company has a market cap of $212,610.00, a PE ratio of 25.05, a price-to-earnings-growth ratio of 1.63 and a beta of 0.66. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. UnitedHealth Group Inc has a fifty-two week low of $156.09 and a fifty-two week high of $231.77.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 5.09% and a return on equity of 22.54%. The firm’s revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the company posted $2.17 earnings per share. equities analysts predict that UnitedHealth Group Inc will post 9.99 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were issued a dividend of $0.75 per share. The ex-dividend date was Thursday, November 30th. This represents a $3.00 annualized dividend and a dividend yield of 1.36%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.09%.

A number of analysts have recently issued reports on the stock. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Cantor Fitzgerald reissued a “buy” rating and set a $235.00 target price on shares of UnitedHealth Group in a research note on Monday. Oppenheimer boosted their target price on shares of UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a research note on Wednesday, October 18th. Finally, Morgan Stanley boosted their target price on shares of UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a research note on Wednesday, October 18th. Three analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $224.98.

ILLEGAL ACTIVITY WARNING: “Ironwood Investment Counsel LLC Acquires Shares of 1,676 UnitedHealth Group Inc (UNH)” was originally published by Week Herald and is the property of of Week Herald. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at https://weekherald.com/2017/12/28/ironwood-investment-counsel-llc-acquires-shares-of-1676-unitedhealth-group-inc-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Ironwood Investment Counsel LLC Acquires Shares of 1,676 UnitedHealth Group Inc (UNH)

Ironwood Investment Counsel LLC acquired a new position in shares of UnitedHealth Group Inc (NYSE:UNH) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,676 shares of the healthcare conglomerate’s stock, valued at approximately $328,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Regal Wealth Group Inc. boosted its stake in shares of UnitedHealth Group by 0.4% during the second quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock valued at $138,000 after purchasing an additional 3 shares during the period. Jackson Grant Investment Advisers Inc. boosted its stake in shares of UnitedHealth Group by 0.4% during the second quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock valued at $204,000 after purchasing an additional 4 shares during the period. RB Capital Management LLC boosted its stake in shares of UnitedHealth Group by 0.4% during the second quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock valued at $321,000 after purchasing an additional 7 shares during the period. Highland Private Wealth Management boosted its stake in shares of UnitedHealth Group by 0.4% during the second quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock valued at $593,000 after purchasing an additional 13 shares during the period. Finally, RNC Capital Management LLC boosted its stake in shares of UnitedHealth Group by 0.7% during the second quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock valued at $360,000 after purchasing an additional 13 shares during the period. 86.01% of the stock is owned by institutional investors.

In other news, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the transaction, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now owns 61,137 shares in the company, valued at approximately $13,652,503.47. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 34,630 shares of company stock worth $7,669,416. Corporate insiders own 0.89% of the company’s stock.

UnitedHealth Group Inc (NYSE:UNH) opened at $220.42 on Thursday. The company has a market cap of $212,610.00, a PE ratio of 25.05, a price-to-earnings-growth ratio of 1.63 and a beta of 0.66. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. UnitedHealth Group Inc has a fifty-two week low of $156.09 and a fifty-two week high of $231.77.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 5.09% and a return on equity of 22.54%. The firm’s revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the company posted $2.17 earnings per share. equities analysts predict that UnitedHealth Group Inc will post 9.99 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were issued a dividend of $0.75 per share. The ex-dividend date was Thursday, November 30th. This represents a $3.00 annualized dividend and a dividend yield of 1.36%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.09%.

A number of analysts have recently issued reports on the stock. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Cantor Fitzgerald reissued a “buy” rating and set a $235.00 target price on shares of UnitedHealth Group in a research note on Monday. Oppenheimer boosted their target price on shares of UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a research note on Wednesday, October 18th. Finally, Morgan Stanley boosted their target price on shares of UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a research note on Wednesday, October 18th. Three analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $224.98.

ILLEGAL ACTIVITY WARNING: “Ironwood Investment Counsel LLC Acquires Shares of 1,676 UnitedHealth Group Inc (UNH)” was originally published by Week Herald and is the property of of Week Herald. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at https://weekherald.com/2017/12/28/ironwood-investment-counsel-llc-acquires-shares-of-1676-unitedhealth-group-inc-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Ironwood Investment Counsel LLC Acquires Shares of 1,676 UnitedHealth Group Inc (UNH)

Ironwood Investment Counsel LLC acquired a new position in shares of UnitedHealth Group Inc (NYSE:UNH) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 1,676 shares of the healthcare conglomerate’s stock, valued at approximately $328,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Regal Wealth Group Inc. boosted its stake in shares of UnitedHealth Group by 0.4% during the second quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock valued at $138,000 after purchasing an additional 3 shares during the period. Jackson Grant Investment Advisers Inc. boosted its stake in shares of UnitedHealth Group by 0.4% during the second quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock valued at $204,000 after purchasing an additional 4 shares during the period. RB Capital Management LLC boosted its stake in shares of UnitedHealth Group by 0.4% during the second quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock valued at $321,000 after purchasing an additional 7 shares during the period. Highland Private Wealth Management boosted its stake in shares of UnitedHealth Group by 0.4% during the second quarter. Highland Private Wealth Management now owns 3,199 shares of the healthcare conglomerate’s stock valued at $593,000 after purchasing an additional 13 shares during the period. Finally, RNC Capital Management LLC boosted its stake in shares of UnitedHealth Group by 0.7% during the second quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock valued at $360,000 after purchasing an additional 13 shares during the period. 86.01% of the stock is owned by institutional investors.

In other news, insider Thomas E. Roos sold 975 shares of the company’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the transaction, the insider now owns 24,630 shares in the company, valued at $5,060,726.10. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the transaction, the director now owns 61,137 shares in the company, valued at approximately $13,652,503.47. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 34,630 shares of company stock worth $7,669,416. Corporate insiders own 0.89% of the company’s stock.

UnitedHealth Group Inc (NYSE:UNH) opened at $220.42 on Thursday. The company has a market cap of $212,610.00, a PE ratio of 25.05, a price-to-earnings-growth ratio of 1.63 and a beta of 0.66. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.52. UnitedHealth Group Inc has a fifty-two week low of $156.09 and a fifty-two week high of $231.77.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. The business had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 5.09% and a return on equity of 22.54%. The firm’s revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the company posted $2.17 earnings per share. equities analysts predict that UnitedHealth Group Inc will post 9.99 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Friday, December 1st were issued a dividend of $0.75 per share. The ex-dividend date was Thursday, November 30th. This represents a $3.00 annualized dividend and a dividend yield of 1.36%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 34.09%.

A number of analysts have recently issued reports on the stock. Credit Suisse Group reissued a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday. Zacks Investment Research lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Cantor Fitzgerald reissued a “buy” rating and set a $235.00 target price on shares of UnitedHealth Group in a research note on Monday. Oppenheimer boosted their target price on shares of UnitedHealth Group from $215.00 to $205.00 and gave the company an “outperform” rating in a research note on Wednesday, October 18th. Finally, Morgan Stanley boosted their target price on shares of UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a research note on Wednesday, October 18th. Three analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $224.98.

ILLEGAL ACTIVITY WARNING: “Ironwood Investment Counsel LLC Acquires Shares of 1,676 UnitedHealth Group Inc (UNH)” was originally published by Week Herald and is the property of of Week Herald. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at https://weekherald.com/2017/12/28/ironwood-investment-counsel-llc-acquires-shares-of-1676-unitedhealth-group-inc-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply